Based on the SMILES representation CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21, the molecule has a half life time in humans after IV administration of 5.100 hours.
Based on the {SMILES__description} {#representation |!}{SMILES#}, the molecule has a {half_life_duration__names__noun} of {half_life_duration#} {half_life_duration__units}.
1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,8-naphthyridine-3-carboxylicacid